Creative Financial Designs’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.2K Hold
72
﹤0.01% 1258
2025
Q4
$17.3K Hold
72
﹤0.01% 1194
2025
Q3
$19.7K Hold
72
﹤0.01% 1149
2025
Q2
$18.6K Sell
72
-24
-25% -$5.72K ﹤0.01% 1163
2025
Q1
$21.5K Buy
96
+28
+41% +$6.54K ﹤0.01% 1067
2024
Q4
$15.6K Buy
68
+56
+467% +$13.5K ﹤0.01% 1109
2024
Q3
$2.93K Buy
+12
New +$2.68K ﹤0.01% 1482
2024
Q2
Sell
-111
Closed -$22K 1709
2024
Q1
$22K Sell
111
-38
-26% -$6.96K ﹤0.01% 939
2023
Q4
$25.6K Hold
149
﹤0.01% 851
2023
Q3
$22K Buy
149
+18
+14% +$3.25K ﹤0.01% 831
2023
Q2
$28.6K Buy
131
+55
+72% +$12.3K ﹤0.01% 775
2023
Q1
$16.6K Buy
+76
New +$16.5K ﹤0.01% 855

Other funds holding RMD

Creative Financial Designs's RMD Position: Q1 2026 in Review

Creative Financial Designs held its ResMed (RMD) position steady in Q1 2026 at 72 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

Creative Financial Designs first reported a position in RMD in Q1 2023 and has held it in 12 quarters since. The position peaked at $28.6K in Q2 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Creative Financial Designs held 72 shares of ResMed worth $16.2K as of Q1 2026.
  • Creative Financial Designs left its ResMed share count unchanged in Q1 2026.
  • ResMed made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #1258 holding.
  • Creative Financial Designs first reported a position in ResMed in Q1 2023 and has held it in 12 quarters since.
  • Creative Financial Designs's ResMed position peaked at $28.6K in Q2 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.